NOTA:FRA
Novartis
123,00 €
0,00%
(0,00) 1D
2. lis, 22:00:00 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NOTA...
Otvori
123,00 €
Najviša
123,00 €
Najniža
123,00 €
Trž. kap.
289,09 mlr.
Prosj. kol.
27,00
Količina
0,00
52-tjed. najviša
145,00 €
52-tjed. najniža
102,50 €
Broj djelatnika
75 tis.
Otvori
123,00 €
Najviša
123,00 €
Najniža
123,00 €
Trž. kap.
289,09 mlr.
Prosj. kol.
27,00
Količina
0,00
52-tjed. najviša
145,00 €
52-tjed. najniža
102,50 €
Broj djelatnika
75 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
AD HOC NEWS
·
prije 7 sati
Novartis stock after-hours at EUR 124.52: minus 0.90 percent versus Lang & Schwarz prior close
Euronext Markets: Real-time Stock Market Data | live
·
prije 9 sati
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen
Pharmaceutical Executive
·
prije 9 sati
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
Quartz
·
prije 9 sati
Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Novartis – informacije
Glavni izvršni direktorVasant Narasimhan
Zaposlenici75,3 tis.
Osnovano7. ožu 1996.
SjedišteBasel, Basel-grad, Švicarska
Sektor-
Web-lokacijanovartis.com